LONDON, February 22, 2018 /PRNewswire/ —
Cambridge research facility will advance BenevolentAI drug programmes into the clinic more quickly and at a much larger scale
BenevolentAI, one of the world’s largest private AI companies, today announced that it has acquired a…
